NEW YORK (dpa-AFX Broker) - The US investment bank Bank of America (BofA) has started the valuation of Schott Pharma shares with a "Buy" rating and a price target of 34 euros. The Mainz-based company is a leader in the storage and administration of pharmaceuticals and offers strong growth, wrote analyst Julien Ouaddour in a study published on Tuesday. The company is also strongly positioned in the best-selling diabetes and weight loss drugs of the GLP-1 class and mRNA active ingredients./ag/ajx

Publication of the original study: 07.11.2023 / Time not specified in study / Time zone not specified in study

First dissemination of the original study: 07.11.2023 / 00:30 / EST